INCY
INCYTE CORPCompany Information
- Company Name
- INCYTE CORP
- CIK
- CIK0000879169
- Category
- Large accelerated filer
- Ticker: Exchange
- INCY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8731
- SIC Description
- Services-Commercial Physical & Biological Research
- Ticker
- INCY
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-15
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 441,797
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 194,324,600
- Shares outstanding
- 199,343,000
- Ownership
- 97.48%
Earnings Market Reaction
- Filing date
- 2026-10-29
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-09-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3,276 | 3,461 | 3,098 | 2,455 | 1,955 | 1,942 | 1,688 | 1,304 | 987 | 3,346 | 3,213 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | - | 467 | 462 | 504 | 443 | ||||||
| Equity Securities Fv Ni | - | - | - | - | - | - | - | 3 | 70 | - | - | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 579 | 555 | 483 | 475 | 467 | 467 | 470 | - | - | - | 443 | ||||||
| Accounts Receivable Net | 1,237 | 1,051 | 1,024 | 896 | 843 | 823 | 853 | 758 | 739 | 746 | 744 | ||||||
| Inventory Net | 134 | 116 | 101 | 83 | 83 | 64 | 59 | 70 | 101 | 64 | 63 | ||||||
| Prepaid Expense And Other Assets Current | 296 | 301 | 318 | 369 | 296 | 212 | 169 | 205 | 208 | 189 | 183 | ||||||
| Assets Current | 5,521 | 5,484 | 5,024 | 4,278 | 3,644 | 3,507 | 3,239 | 2,809 | 2,567 | 4,849 | 4,645 | ||||||
| Restricted Cash Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | - | - | 288 | 188 | ||||||
| Equity Securities F V N I Noncurrent | 91 | 55 | 48 | 22 | 13 | 17 | 19 | 28 | 30 | - | 188 | ||||||
| Inventory Noncurrent | 342 | 331 | 342 | 367 | 368 | 365 | 348 | 298 | 255 | 264 | 207 | ||||||
| Property Plant And Equipment Net | 701 | 720 | 731 | 799 | 799 | 765 | 763 | 773 | 762 | 720 | 752 | ||||||
| Finance Lease Right Of Use Asset | - | 27 | 28 | 28 | 29 | 30 | 31 | 25 | 26 | 26 | 26 | ||||||
| Other Intangible Assets Net | 103 | 110 | 117 | 119 | 126 | 108 | 114 | 120 | 114 | 118 | 124 | ||||||
| Goodwill | 133 | 133 | 133 | 156 | 156 | 156 | 156 | 156 | 156 | 156 | 156 | ||||||
| Deferred Income Tax Assets Net | 282 | 453 | 515 | 528 | 652 | 769 | 762 | 762 | 730 | 667 | 632 | ||||||
| Other Assets Noncurrent | 88 | 24 | 18 | 32 | 33 | 30 | 11 | 40 | 22 | 47 | 52 | ||||||
| Assets | 7,287 | 7,339 | 6,958 | 6,330 | 5,821 | 5,749 | 5,444 | 5,012 | 4,662 | 7,136 | 6,782 | ||||||
Liabilities Current | |||||||||||||||||
| Accounts Payable Current | 235 | 229 | 210 | 172 | 241 | 196 | 197 | 179 | 148 | 164 | 110 | ||||||
| Employee Related Liabilities Current | 191 | 125 | 228 | 168 | 129 | 103 | 189 | 151 | 114 | 89 | 153 | ||||||
| Accrued Liabilities Current | 967 | 1,092 | 1,032 | 948 | 857 | 1,376 | 1,212 | 1,128 | 1,034 | 1,102 | 936 | ||||||
| Finance Lease Liability Current | - | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | ||||||
| Business Combination Contingent Consideration Liability Current | 40 | 39 | 41 | 46 | 47 | 42 | 39 | 40 | 37 | 37 | 38 | ||||||
| Liabilities Current | 1,438 | 1,490 | 1,515 | 1,339 | 1,279 | 1,720 | 1,642 | 1,502 | 1,337 | 1,396 | 1,240 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 52 | 71 | 80 | 138 | 160 | 153 | 154 | 167 | 157 | 165 | 174 | ||||||
| Finance Lease Liability Noncurrent | - | 29 | 30 | 31 | 32 | 33 | 34 | 28 | 29 | 29 | 29 | ||||||
| Other Liabilities Noncurrent | 127 | 127 | 165 | 171 | 180 | 176 | 168 | 145 | 142 | 151 | 149 | ||||||
| Liabilities | 1,644 | 1,716 | 1,790 | 1,679 | 1,650 | 2,082 | 1,997 | 1,841 | 1,665 | 1,741 | 1,592 | ||||||
Stockholders Equity | |||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 5,311 | 5,083 | 4,928 | 4,722 | 4,667 | 4,588 | 4,533 | 4,429 | 4,383 | 5,070 | 5,016 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 13 | 22 | 25 | 15 | 13 | -6 | -13 | 16 | -5 | -6 | 13 | ||||||
| Retained Earnings Accumulated Deficit | 318 | 517 | 214 | -86 | -510 | -915 | -1,073 | -1,274 | -1,380 | 330 | 160 | ||||||
| Stockholders Equity | 5,643 | 5,623 | 5,167 | 4,651 | 4,171 | 3,668 | 3,448 | 3,171 | 2,997 | 5,394 | 5,190 | ||||||
| Liabilities And Stockholders Equity | 7,287 | 7,339 | 6,958 | 6,330 | 5,821 | 5,749 | 5,444 | 5,012 | 4,662 | 7,136 | 6,782 | ||||||
| Debt Securities Available For Sale Amortized Cost Current | - | - | - | - | - | - | - | 464 | 464 | 506 | 443 | ||||||
| Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Current | 586 | 555 | 481 | 473 | 465 | 466 | 470 | - | - | - | 443 | ||||||
| Debt Securities Available For Sale Allowance For Credit Loss | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 204 | 200 | 198 | 196 | 194 | 194 | 193 | 193 | 192 | 225 | 224 | ||||||
| Shares Outstanding | 204 | 200 | 198 | 196 | 194 | 194 | 193 | 193 | 192 | 225 | 224 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialINCYTE CORP (INCY) — SEC Financial Statements & Analysis
INCYTE CORP (INCY) is a services-commercial physical & biological research company, incorporated in DE. INCYTE CORP trades on Nasdaq as: INCY. INCYTE CORP (INCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-10-29. Based on that filing, INCYTE CORP carries a market cap of $24.66B, a P/E ratio of 101.93x, a P/B ratio of 4.37x, a P/S ratio of 4.32x, an enterprise value of $21.39B, and an EV/EBITDA multiple of 41.25x. On profitability, it posts a gross margin of 92.40%, an operating margin of 6.53%, a net margin of 4.24%, a Return on Equity (ROE) of 4.93%, a Return on Assets (ROA) of 3.69%, and a Return on Invested Capital (ROIC) of 7.09%. Per share, it reports EPS of $1.19, diluted EPS of $1.19, free cash flow per share of $8.06, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.38% year-over-year, net income growth of -72.21% year-over-year, and EPS growth of -73.48% year-over-year. On the balance sheet, it maintains a current ratio of 3.84x, a quick ratio of 3.54x, working capital of $4.08B, a debt-to-equity ratio of 0.29x, a debt ratio of 0.23, an interest coverage ratio of 158.49x, free cash flow of $1.64B (TTM), and net debt of $-3.28B. Figures sourced from SEC EDGAR.
- Market Cap
- $24.66B
- P/E TTM
- 101.93x
- EPS TTM
- $1.19
- P/B TTM
- 4.37x
- ROE TTM
- 4.93%
- ROA TTM
- 3.69%
- Debt To Equity
- 0.29x
- Free Cash Flow TTM
- $1.64B
- Net Revenue TTM Growth 1Y
- 24.38%
Data as of 2026-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INCYTE CORP in?
INCYTE CORP (INCY) operates in the Services-Commercial Physical & Biological Research industry.
What exchange does INCY trade on?
INCYTE CORP (INCY) trades on the Nasdaq.
Where is INCYTE CORP incorporated?
INCYTE CORP is incorporated in DE.
When was INCYTE CORP (INCY)'s most recent SEC filing?
INCYTE CORP (INCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-09-30, filed with the SEC on 2026-10-29.
What is INCY's market cap?
INCYTE CORP (INCY) has a market capitalization of $24.66B as of 2026-09-30.
What is INCY's P/E ratio?
INCYTE CORP (INCY)'s trailing twelve month P/E ratio is 101.93x as of 2026-09-30.
What is INCY's EPS (earnings per share)?
INCYTE CORP (INCY)'s trailing twelve month EPS is $1.19 as of 2026-09-30.
What is INCY's ROE (return on equity)?
INCYTE CORP (INCY)'s trailing twelve month Return on Equity (ROE) is 4.93% as of 2026-09-30.
What is INCY's ROA (return on assets)?
INCYTE CORP (INCY)'s trailing twelve month Return on Assets (ROA) is 3.69% as of 2026-09-30.
What is INCY's ROIC (return on invested capital)?
INCYTE CORP (INCY)'s trailing twelve month Return on Invested Capital (ROIC) is 7.09% as of 2026-09-30.
What is INCY's EV/EBITDA?
INCYTE CORP (INCY)'s trailing twelve month EV/EBITDA is 41.25x as of 2026-09-30.